A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
Status:
Active, not recruiting
Trial end date:
2021-12-22
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the safety and tolerability of the study
drug LY3457263 in healthy participants and participants with type 2 diabetes. Blood tests
will be performed to investigate how the body processes the study drug and how the study drug
affects the body. The study has two parts (part A and B). Each part will last up to 10 weeks
and may include up to either 13 (part A) or 19 (part B) visits.